Nunn, Alistair V. W. http://orcid.org/0000-0003-0728-1995
Guy, Geoffrey W.
Brysch, Wolfgang
Botchway, Stanley W.
Frasch, Wayne
Calabrese, Edward J.
Bell, Jimmy D.
Article History
Received: 20 August 2020
Accepted: 20 October 2020
First Online: 9 November 2020
Ethics approval and consent to participate
: None required.
: All authors have approved the paper for publication.
: Professor Geoffrey Guy is the Founder and Chairman of GW Pharmaceuticals; Professor Alistair Nunn is a scientific advisor to GW Pharmaceuticals; Dr. Wolfgang Brysch is the Chief Executive Officer of MetrioPharm AG. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.